Coronary Artery Disease
Comprehensive Cardiovascular Risk Management in Primary Care
Understanding Coronary Artery Disease
Coronary artery disease (CAD) occurs when the coronary arteries — which supply the heart muscle with blood — become narrowed or blocked by atherosclerotic plaques (buildup of cholesterol, fat, and inflammatory cells). CAD is the leading cause of death in the United States for both men and women. Primary care plays a central role in managing established CAD and in preventing its development in high-risk individuals.
Signs & Symptoms
- Angina: chest pain, tightness, or pressure — often with exertion
- Shortness of breath
- Fatigue, especially with activity
- Palpitations
- Many patients with significant CAD have no symptoms until a heart attack
- Heart attack symptoms: crushing chest pain, pain radiating to arm/jaw, sweating, nausea — call 911
Our Management Approach
For patients with established CAD or high cardiovascular risk, we provide guideline-directed medical therapy — including antiplatelet therapy, statins, ACE inhibitors, and beta-blockers as appropriate — along with comprehensive risk factor management. We coordinate with cardiologists and ensure your follow-up care is seamless.
Treatment Goals
- Prevent first or recurrent heart attack
- LDL below 70 mg/dL in high-risk patients
- Blood pressure below 130/80 mmHg
- Smoking cessation
- Optimized medications with minimal side effects
Lifestyle Recommendations
- •Heart-healthy Mediterranean diet: fish, vegetables, olive oil, nuts, whole grains
- •Cardiac rehab or supervised exercise program if post-cardiac event
- •Strict smoking cessation — the most impactful single intervention
- •Alcohol moderation: no more than 1 drink/day
- •Stress and anger management — emotional stress is a cardiac trigger
- •Daily aspirin only if specifically prescribed — do not self-prescribe
Medications & Treatment Options
- 💊Antiplatelet: aspirin 81 mg daily post-MI or high-risk; dual antiplatelet (aspirin + P2Y12 inhibitor clopidogrel/ticagrelor) post-stent for 12 months
- 💊Statins: high-intensity (atorvastatin 80 mg, rosuvastatin 40 mg) regardless of baseline LDL
- 💊Beta-blockers: metoprolol succinate (Toprol), carvedilol (Coreg) — post-MI cardioprotective
- 💊ACE inhibitors/ARBs: lisinopril, ramipril, valsartan — post-MI, especially if LVEF <40% or diabetes
- 💊Additional: nitrates (nitroglycerin, isosorbide) for angina; ranolazine for refractory angina; calcium channel blockers if beta-blocker intolerant
Monitoring Schedule
Post-acute event: weekly for 4 weeks, then monthly for 3 months, then every 3 months; stress testing or imaging per cardiology; lipid panel and renal function every 3–6 months
Clinical Protocol
Acute MI: transfer to PCI-capable facility if possible; provide dual antiplatelet therapy, high-intensity statin, beta-blocker, ACE-I. Chronic CAD: optimal medical therapy with high-intensity statin + beta-blocker + ACE-I ± aldosterone antagonist (if LVEF <40%). Goal BP <130/80. Functional assessment: encourage exercise stress testing or imaging to risk-stratify. Screen for heart failure, arrhythmia, ischemia periodically. Coordinate with cardiology for complex cases or high-risk presentations.
When to Seek Urgent Care
- →Any chest pain at rest or with minimal exertion — call 911
- →New or worsening shortness of breath
- →Sudden severe fatigue or dizziness
- →Palpitations with chest discomfort
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Individual treatment plans vary. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment.
Managing Heart Disease?
Book a telehealth visit with Pineapple Primary Care to get a personalized coronary artery disease management plan.
Book an AppointmentQuick Facts
- ✓Prevent first or recurrent heart attack
- ✓LDL below 70 mg/dL in high-risk patients
- ✓Blood pressure below 130/80 mmHg